Holen Sie sich die Stockscreener-App
40.75
4.89%
1.90
Vorhandelsmarkt:
40.56
-0.19
-0.47%
Schlusskurs vom Vortag:
$38.85
Offen:
$38.82
24-Stunden-Volumen:
1.62M
Relative Volume:
1.51
Marktkapitalisierung:
$1.21B
Einnahmen:
$442.68M
Nettoeinkommen (Verlust:
$-77.81M
KGV:
-15.27
EPS:
-2.6684
Netto-Cashflow:
$-28.65M
1W Leistung:
-0.05%
1M Leistung:
-39.59%
6M Leistung:
-68.18%
1J Leistung:
-35.94%
1-Tages-Spanne:
$37.64
$42.10
1-Wochen-Bereich:
$37.64
$43.00
52-Wochen-Spanne:
$32.21
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
888-729-1206
Adresse
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, WAT, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
40.75 | 1.15B | 442.68M | -77.81M | -28.65M | -2.6684 |
TMO
Thermo Fisher Scientific Inc
|
438.34 | 166.56B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
161.91 | 116.46B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
528.79 | 42.03B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
329.22 | 32.72B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
111.70 | 32.01B | 7.07B | 1.29B | 993.00M | 4.5355 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-05-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
Alle ansehen
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
Does GENEDX HOLDINGS (WGS) Have the Potential to Rally 26.17% as Wall Street Analysts Expect? - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdin - The National Law Review
GeneDx Holdings (WGS) price target decreased by 32.59% to 98.94 - MSN
Comerica Bank Sells 29,753 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
WGS stock slumps after hours as firm predicts lower test volume for year - MSN
GeneDx Fraud Probes And Guidance Cut Put Valuation Gap In Focus - simplywall.st
Number of shareholders of GeneDx Holdings Corp. – NASDAQ:WGS - TradingView
A Look At GeneDx Holdings (WGS) Valuation After Earnings Miss Guidance Cut And Securities Investigation - Yahoo Finance
GeneDx Holdings (WGS) upgraded to strong buy: Here's what you should know - MSN
UBS Group AG Decreases Stake in GeneDx Holdings Corp. $WGS - MarketBeat
Corvex management, director Keith Meister buy $13.7m GeneDx stock By Investing.com - Investing.com South Africa
Corvex management, director Keith Meister buy $13.7m GeneDx stock - Investing.com India
Corvex-linked funds boost GeneDx (WGS) stake with 351K-share open-market buy - Stock Titan
Casdin and Meister report 12% and 17.9% GeneDx (WGS) stakes - Stock Titan
GeneDx (NASDAQ:WGS) Shares Up 6.9%Still a Buy? - MarketBeat
GeneDx WGS Slides On Guidance Cut As Insiders Buy The Dip - StocksToTrade
GeneDx expects $475M-$490M 2026 revenue as it targets at least 30% exome/genome volume growth - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp.WGS - PR Newswire
GeneDx Q1 2026 misses targets; lower-margin genomic tests slow growth, but turnaround potential remains. - Pluang
GeneDx (WGS) Fell Despite Continued Execution Improvement - Insider Monkey
Levi & Korsinsky Announces Investigation of Securities Claims Against GeneDx Holdings Corp. (WGS) - GlobeNewswire
GeneDx: Disappointing Q1 Creates Another Turnaround Opportunity (NASDAQ:WGS) - Seeking Alpha
GeneDx Holdings, Duolingo, Kosmos Energy and other big stocks moving lower in Tuesday's pre-market session - MSN
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
WGS SHAREHOLDER ALERT: Investors Encouraged to Contact - GlobeNewswire
WGS Investor Alert: Levi & Korsinsky Investigates GeneDx Holdings Corp. (WGS) for Potential Securities Fraud - Morningstar
GeneDx Holdings Corp. (NASDAQ:WGS) Analysts Just Slashed This Year's Revenue Estimates By 12% - simplywall.st
GeneDx: The 50% Crash Creates A Compelling Entry (NASDAQ:WGS) - Seeking Alpha
Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - FinancialContent
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect - ACCESS Newswire
2026-05-12 | Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect | NDAQ:WGS | Press Release - Stockhouse
Monday’s insider activity: GeneDx director buys $46.8M in stock By Investing.com - Investing.com Australia
Monday’s insider activity: GeneDx director buys $46.8M in stock - Investing.com UK
Genedx Holdings Insider Bought Shares Worth $46,806,729, According to a Recent SEC Filing - marketscreener.com
Corvex funds linked to Keith Meister buy 1.2M GeneDx (WGS) shares - Stock Titan
GeneDx holdings: director Keith Meister-affiliated entities buy $46.8m By Investing.com - Investing.com Nigeria
GeneDx holdings: director Keith Meister-affiliated entities buy $46.8m - Investing.com
Casdin fund boosts GeneDx (WGS) exposure via 850K share swaps - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect - ACCESS Newswire
WGS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - ChartMill
TradingKey - TradingKey
Law firm investigates GeneDX for possible securities violations after stock drops 45% on weak revenue guidance - Pluang
WGS: GeneDX Investors Should Contact Block & Leviton to Possibly Recover Losses - marketscreener.com
Number of shareholders of GeneDx Holdings Corp. – NASDAQ:WGSWW - TradingView
symbol__ Stock Quote Price and Forecast - CNN
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
GeneDx (WGS) Q1 2025 Earnings Call Transcript - AOL.com
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & G - The National Law Review
GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm - The Daily Tribune News
Will robust exome and genome revenues lift GeneDx's Q1 earnings? - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):